Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for 3-D Matrix Ltd. (7777:JPX), powered by AI.
3-D Matrix Ltd. is currently trading at ¥341. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for 3-D Matrix Ltd. on Alpha Lenz.
3-D Matrix Ltd.'s P/E ratio is -13.5.
“3-D Matrix Ltd. trades at a P/E of -13.5 (undervalued) with modest ROE of -194.7%. 3Y revenue CAGR of 66.4% highlights clear growth momentum.”
Ask for details →3-D Matrix Ltd. is a notable player in the realm of biotechnology, specializing in innovative regenerative medicine technologies. The company is particularly focused on the development and commercialization of its patented self-assembling peptide technology, which is designed to enhance the body’s natural healing processes. This technology finds its application in various medical fields, including surgery and wound care, where it aims to improve patient outcomes by accelerating recovery times and minimizing complications. By catering to the healthcare and pharmaceutical industries, 3-D Matrix Ltd. significantly impacts how modern regenerative treatments are developed and implemented. Operating within Japan and having collaborations globally, it seeks to address complex medical challenges with its cutting-edge solutions, thereby holding a pivotal role in advancing medical science and improving health standards worldwide.
“3-D Matrix Ltd. trades at a P/E of -13.5 (undervalued) with modest ROE of -194.7%. 3Y revenue CAGR of 66.4% highlights clear growth momentum.”
Ask for details →3-D Matrix Ltd. (ticker: 7777) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 114 employees. Market cap is $33.8B.
The current price is 341 with a P/E ratio of -13.53x and P/B of 15.27x.
ROE is -194.69% and operating margin is -16.67%. Annual revenue is $6.9B.